The influence of an innovative antibacterial drug of the thiadiazinone class on the virulence factors of bacteria of the phylum Pseudomonadota, which chronically infect patients with cystic fibrosis
Article in Zhurnal Mikrobiologii Epidemiologii i Immunobiologii (May 2024)